Naturally acquired immunity to falciparum malaria protects millions of people routinely
exposed to Plasmodium falciparum infection from severe disease and death. There is no …

Immune signatures measured at baseline and immediately prior to vaccination may predict
the immune response to vaccination. Such pre-vaccine assessment might allow not only …

Although there has been major recent progress in malaria vaccine development, substantial
challenges remain for achieving highly efficacious and durable vaccines against …

Health care workers (HCW) are a high-risk population to acquire SARS-CoV-2 infection from
patients or other fellow HCW. This study aims at estimating the seroprevalence against …

Background Ivermectin inhibits the replication of SARS-CoV-2 in vitro at concentrations not
readily achievable with currently approved doses. There is limited evidence to support its …

Background The RTS, S/AS01 vaccine targets the circumsporozoite protein of Plasmodium
falciparum and has partial protective efficacy against clinical and severe malaria disease in …

Unraveling the long-term kinetics of antibodies to SARS-CoV-2 and the individual
characteristics influencing it, including the impact of pre-existing antibodies to human …

Background Maternal mortality is a major health problem concentrated in resource-poor
regions. Accurate data on its causes using rigorous methods is lacking, but is essential to …

Background We performed a population-based study to describe the impact of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on pregnancy outcomes …

Background Two doses of mRNA vaccination have shown> 94% efficacy at preventing
COVID-19 mostly in naïve adults, but it is not clear if the second dose is needed to maximize …